Incyte Corporation
INCY
$113.27+1.52%
End of day · as of Oct 16, 2026, 8:00 AM ET
Mkt cap
$20.45B
EV/Sales
3.38
P/E ratio
N/A
FY2025 Revenue
$5.14B
EPS (9mo ended 2025-09-30)
$4.95
Gross Margin (FY2025)
92.76%
Profit Margin (FY2025)
25.03%
Beta
0.79
Div yield
N/A
Sector
Healthcare
Incyte Corporation (INCY) is a biotechnology company listed on US.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B.
Use this INCY research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full INCY income, balance, and cash tables.
Incyte Corporation (INCY) is a biotechnology company in the Healthcare sector.
Latest cached Incyte Corporation (INCY) revenue for Dec 31, 2025 was $5.14B. Net income was $1.29B. Statements: https://lician.com/financials/incy
Incyte Corporation (INCY) market capitalization is $20.45B on the latest cached snapshot.
Incyte Corporation (INCY) cached previous close $111.57; day range $112.71 – $113.27; volume 1,914,412. Session quote: https://lician.com/quote/incy
Incyte Corporation (INCY) latest cached earnings event is "INCY earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached INCY filing is 8-K · Aug 31, 2026. Filings: https://lician.com/sec/incy